Developing evolution-resistant drugs for COVID-19

Analyzing how mutations affect the main protease of SARS-CoV-2 may help researchers develop drugs that are effective against current and future variants of the virus.

Detalles Bibliográficos
Autor principal: Weinreich, Daniel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Evolutionary Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322998/
https://www.ncbi.nlm.nih.gov/pubmed/35880850
http://dx.doi.org/10.7554/eLife.81334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322998/
https://www.ncbi.nlm.nih.gov/pubmed/35880850
http://dx.doi.org/10.7554/eLife.81334

Ejemplares similares